Our healthcare is marred by poor infrastructure, negligence, and pharma-doctor collusion. Sumanth C Raman's book exposes all this and more, questioning why it doesn't evoke as much anger in Indians
India has emerged as a premier destination for conducting global clinical trials, an Indian bureaucrat who is also a Harvard scholar has said, asserting that the pharma industry must recognise the country's intrinsic value as a primary location rather than relegating it to a secondary backup role. Speaking at a recent Bio-Pharma summit in Boston, Dr Mrinalini Darswal, an Indian diplomat who is currently a PhD scholar at Harvard University, said that India "boasts a robust infrastructure, a cadre of seasoned investigators, and cost-effectiveness, collectively rendering it an appealing choice for such endeavours. The present aspirational India under the strong and transformative leadership of our Prime Minister Narendra Modi has emerged as a premier destination for conducting global clinical trials, having streamlined its regulatory framework and elevated its compliance standards to align with international good clinical practices, Darswal said. This starkly contrasts larger economies
Wipro's medicare prescription payment plan platform will streamline prescription payments
The merger will happen in a phased manner over the next 24-30 months. The combined entity is expected to deliver Rs 25,000 crore of revenue in three years with 7-8 per cent EBITDA
The hospital and Chennai-based NGO helped Pakistani family settle bill of more than Rs 35 lakh for the transplant
Coverage under India's flagship Ayushman Bharat scheme may double to Rs 10 lakh; scheme may integrate various national and state health programmes
Prophylactic treatment can reduce number of bleeds per year, improve quality of life, say experts
World Liver Day gives an opportunity to teach people about the risk factors for liver infection, which incorporate liquor consumption, obesity, viral hepatitis, and certain drugs
Aster DM Healthcare, which netted around USD 907 million from the sale of its GCC business, looks to plough around Rs 1,000 crore into its expansion plans in India as it targets a bed capacity of over 6,600 in the next three years. The healthcare company plans to add 1,700 beds by 2026-27 through organic and inorganic routes. The company's board last week also approved a special dividend of Rs 118 per share to its shareholders following the booster shot from the divestment of the GCC business. Aster DM Healthcare recently concluded the sale of its GCC businesses for a cash consideration of USD 907.6 million. The record date for determining the entitlement of the shareholders to special dividend is April 23, 2024. Aster DM Healthcare shares rallied more than 14 per cent on Monday to hit a fresh 52-week high on BSE, bucking a weak trend in the broader market. The stock hit a year high of Rs 558.30 per share before closing at Rs 522.75 on BSE, up by 7.13 per cent over the previous ..
Lok Sabha elections 2024: The manifesto pledged to conduct a nationwide Socio-Economic and Caste Census to assess caste and sub-caste demographics along with their socio-economic status
The study also revealed that nearly half of all deliveries in private hospitals were C-sections (caesarean sections)
Education and health outcomes will need to be improved
Wipro GE Healthcare on Tuesday said it will invest over Rs 8,000 crore in India over the next five years to increase local manufacturing and research and development (R&D) initiatives. The company, a leading global medical technology, pharmaceutical diagnostics, and digital solutions provider, said as a part of the investment, its 'Made in India' PET CT Discovery IQ scanner will be exported to 15 countries. Additionally, locally produced Revolution Aspire CT, Revolution ACT and MR breast coils will be manufactured 'In India for the World', the company said in a statement. The strategic investment bolsters the company's local manufacturing footprint to address the growing domestic and international market. It will also build supply chain resiliency for the organisation, it added. Wipro GE Healthcare Chairman Azim Premji said India is riding the resurgent growth in the healthcare industry and rapidly expanding MedTech sector. "With 'Make in India', we are witnessing an exponential .
A standard rate chart for hospitals across the country is impractical as it doesn't consider real estate costs that vary widely across locations
More than 1 core health cards under the 'Ayushman Bharat Pradhan Mantri Jan Arogya Yojana' were issued in Bihar during a six-day special campaign from March 2, Deputy Chief Minister Samrat Chaudhary said. The NDA government in the state has decided to provide "free medical treatment up to Rs 5 lakh every year to all ration card holders of the state under the Ayushman scheme", he said. "Issuance of Ayushman Bharat cards to 1.03 crore families in just six days (till 11 am of March 8) is a big achievement of our government in the state," the deputy chief minister told PTI. All ration card holders covered under the National Food Security Act (NFSA) get 5 kg of rice, and now, they will avail of free treatment up to Rs 5 lakh every year, Chaudhary said. "At present, around 1.2 crore families in the state are availing of Ayushman Bharat benefits. Now, 1.03 crore families, who are beneficiaries under the NFS Act, have also been added," said Chaudhary, who holds the health department ...
Highlighting India's growing need for assistive technologies to cope with disabilities or chronic illnesses, experts at a recent event stressed the need for evidence-based research and collaboration to bridge the gap between these products and their end-users. The experts at a session on 'Growing Need for Assistive Technologies' at the 8th National Health Writers and Influencers Convention, held at AIIMS, asserted that India has a huge and growing demand for assistive technologies (ATs) to help about 250 million people who need them to cope with disabilities, ageing or chronic illnesses. Speaking on the occasion, Dr R K Srivastava, former director general of health services at the Union Health Ministry, said 18 per cent of India's population requires assistive care solutions such as spectacles, hearing aids, wheelchairs, communication aids and prosthetic limbs. Dr Ashoo Grover, Scientist 'F' and Deputy Director General of the Indian Council of Medical Research, said ICMR and other .
Considering the requirement of quality in-patient care, Ayush hospitals should be spread across the country following the bed per population norm, according to a set of new guidelines issued by the Ayush Ministry. According to the norm, one hospital bed per 5,000 population is "essential" while 1 bed per 2,000 population is "desirable". There are 3,844 Ayush hospitals in various categories across the country run by central and state governments. These hospitals together have a bed strength of 60,943. The "essential" number of beds in Ayush hospitals may be provided through the public health system such as medical colleges, district hospitals, 10-bedded, 30-bedded, 50 or more bedded Ayush hospitals, the Indian Public Health Standards (IPHS) for Ayush healthcare facilities stated. To achieve the "desirable" number of beds, the contribution of the private sector may also be considered while continuing to strengthen and increase bed provision at public health facilities, the guideline
Executive chairperson of Antara Senior Care says 'service delivery' has to be the cornerstone of senior care industry
Additionally, Uttar Pradesh maintains the leading position in terms of the highest number of Ayushman cards issued compared to other states